Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Expanded age indication for GSK’s AREXVY

GSK raises USD 1.24 billion from latest Haleon stake sale

Ruchika Sharma17 Jan 2024 5:38 PM IST

New Delhi: GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business...

USFDA approves Takeda Gammagard liquid ERC for primary immunodeficiency

Takeda Hyqvia gets USFDA nod for Chronic Inflammatory Demyelinating Polyneuropathy

Ruchika Sharma17 Jan 2024 3:54 PM IST

Osaka: Takeda has announced that the U.S. Food and Drug Administration (FDA) has approved HYQVIA [Immune Globulin Infusion 10% (Human) with...

UP Govt to host 'Pharma Conclave' in Hyderabad to boost investments

Ruchika Sharma17 Jan 2024 3:09 PM IST

Hyderabad: The Government of Uttar Pradesh (GoUP) will host a 'Pharma Conclave' here on January 18.In collaboration with industry associations,...

WHO grants Emergency Use Listing to Biological E Corbevax vaccine

Ruchika Sharma17 Jan 2024 12:34 PM IST

Hyderabad: Biological E. Limited, a Hyderabad-based Vaccines and Pharmaceutical company, has announced that the World Health Organisation (WHO)...

Piramal Pharma arm, BrePco Biopharma get UKMHRA approval for Neoatricon in UK

Piramal Critical Care unveils new 10mg/10mL (1 mg/mL) concentration of Zinc Sulfate for Injection in US

Ruchika Sharma17 Jan 2024 11:37 AM IST

Bethlehem: Piramal Critical Care (PCC), a division of Piramal Pharma Limited, has announced the launch of a new 10mg/10mL (1 mg/mL) concentration...

Bill & Melinda Gates Foundation announces largest annual budget of USD 8.6 billion for 2024

Ruchika Sharma16 Jan 2024 1:30 PM IST

A major focus for the foundation has been on reducing inequities in health by funding the development of new tools and strategies to reduce the burden...

GSK buys IDRx for up to USD 1.15 billion

CCI clears Seventy Second Investment stake acquisition in Manipal Health Enterprises

Ruchika Sharma16 Jan 2024 12:30 PM IST

New Delhi: Fair trade regulator Competition Commission of India (CCI) has cleared Seventy Second Investment Company's proposed stake acquisition...

University of Oxford scientists launch first human vaccine trials for deadly Nipah virus

Ruchika Sharma16 Jan 2024 11:43 AM IST

UK: Scientists at the University of Oxford in the UK have launched first-in-human vaccine trials for the deadly Nipah virus which impacts many...

Union Budget 2024: Pharma industry seeks fiscal incentives for RnD

Ruchika Sharma15 Jan 2024 1:30 PM IST

New Delhi: The pharma industry has sought fiscal incentives to promote research and development (R&D) in the sector, as it is likely to reach...

Yet to take decision on roll-out of HPV vaccination against cervical cancer: Govt

Ruchika Sharma15 Jan 2024 12:30 PM IST

New Delhi: The Union Health Ministry has said it has yet to take a decision on the roll-out of HPV vaccination against cervical cancer in the country....

Lupin Manufacturing Solutions: Empagliflozin API gets CADIFA approval from ANVISA, Brazil

Lupin bags USFDA nod for hypertension drug Propranolol Hydrochloride ER

Ruchika Sharma15 Jan 2024 11:48 AM IST

Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug Administration (U.S....

EU regulator starts safety review of CAR-T cancer cell therapies

Ruchika Sharma15 Jan 2024 9:00 AM IST

The European Union's drug watchdog has said it had started a review into the safety risks associated with cancer cell therapies made by companies such...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok